optikira.com
OptiKiraPreventing Cell Death
http://www.optikira.com/
Preventing Cell Death
http://www.optikira.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
0.5 seconds
PAGES IN
THIS WEBSITE
7
SSL
EXTERNAL LINKS
1
SITE IP
198.185.159.145
LOAD TIME
0.484 sec
SCORE
6.2
OptiKira | optikira.com Reviews
https://optikira.com
Preventing Cell Death
optikira.com
News — OptiKira
http://www.optikira.com/news
February 9, 2017. OptiKira Receives Significant Grant from ALS Association. February 9, 2017. Source: http:/ www.alsa.org/news/media/press-releases/drug-development-contracts-020917.html. June 13, 2016. Arix Bioscience Supports Optikira, A Company Developing Drugs to Fight Blindness. June 13, 2016. September 30, 2015. Optikira Awarded Two NIH Grants. September 30, 2015. OptiKira has been awarded two NIH grants to support the development of novel therapeutics that prevent cell death caused by misfolded or...
Partners — OptiKira
http://www.optikira.com/partners
BioMotiv, the for-profit accelerator of The Harrington Project. Is the developer and lead funder of OptiKira. BioMotiv aims to advance a portfolio of discoveries into new medicines through an innovative, mission-driven model that efficiently aligns capital and collaborations for the benefit of inventors and investors, and ultimately physicians and patients. Learn more about BioMotiv here. Learn more about Arix Bioscience here. Subscribe to OptiKira Updates.
Scientific Founders — OptiKira
http://www.optikira.com/scientific-founders
Bradley Backes, Ph.D. Dustin Maly, Ph.D. Scott Oakes, M.D. Feroz Papa, M.D., Ph.D. Subscribe to OptiKira Updates.
Overview — OptiKira
http://www.optikira.com/overview
Α is the master regulator of the UPR, directing the cellular response towards the adaptive or terminal pathways. Our academic Founders made the seminal discovery that certain small molecule kinase inhibitors can effectively block the terminal pathway. They have demonstrated that these compounds, which they have named kinase-inhibiting RNase attenuators (KIRAs), can protect cells from degeneration in preclinical models of retinitis pigmentosa (RP) and diabetes. Subscribe to OptiKira Updates.
Project Leadership — OptiKira
http://www.optikira.com/project-leadership
Richard Keenan, Project Director. Glen Gaughan, Project Manager. Subscribe to OptiKira Updates.
TOTAL PAGES IN THIS WEBSITE
7
Scientific Publications & News | Gfee Bio
http://gfreebio.com/publicationsnews.html
Publications & News. Publications & News. Gfree Bio has been awarded an NIH Phase I STTR grant from NIGMS for a program titled: Polar samplng and optimization of protein-ligand cocrystal structures. Dr. Charles H. Reynolds, Founder of Gfree Bio, is Principal Investigator. Gfree Bio to present at the CCG UGM. Gfree Bio collaborator Nirvana Sciences. Has been awarded Phase II NIH SBIR grant. Gfree Bio founder presented at the ACS National meeting in San Diegothemputers in Chemistry MPPG session. Two recent...
TOTAL LINKS TO THIS WEBSITE
1
Welcome optikinnovision.com - Justhost.com
Web Hosting from Just Host. Design By Design Fusions.
OptiKinspect | Just another WordPress.com weblog
Juin 8, 2009. Regard sur le bâtiment. 8212; austerlitz75 @ 7:16. Connaissez-vous l’effet de cheminée? Dans un bâtiment en général, l’effet de cheminée peut produire des effets pervers sur l’enveloppe du bâtiment. Voici un article du conseil national de recherches Canada sur le sujet : http:/ irc.nrc-cnrc.gc.ca/pubs/cbd/cbd104 f.html. 8212; austerlitz75 @ 6:41. Voici un blog voué à la technologie du bâtiment. Présentement en construction. Propulsé par WordPress.com.
OPTIK INTAN
Rabu, 17 Oktober 2012. Pada kondisi normal, saat mata beristirahat, bayangan dapat fokus tepat di retina sehingga penglihatan tajam dan jelas. Namun, kelainan refraksi bukan berarti mata Anda sedang sakit. Memiliki kelainan refraksi berarti mata Anda membutuhkan alat bantu agar dapat melihat dengan jelas. Ada beberapa macam kelainan refraksi, seperti miopia atau rabun jauh. Kondisi itu keadaan di mana bayangan sinar jatuh di depan retina. Yang kedua adalah hipermetropia atau rabun dekat. Apakah menggunak...
OptikInternet.com is available at DomainMarket.com
Ask About Special April Deals! What Are the Advantages of a Super Premium .Com Domain? 1 in Premium Domains. 300,000 of the World's Best .Com Domains. Available For Immediate Purchase. Safe and Secure Transactions. 24/7 Customer Support: 888-694-6735. Search For a Premium Domain. Or Click Here To Get Your Own Domains Appraised. Find more domains similar to OptikInternet.com. We are constantly expanding our inventory to give you the best domains available for purchase! Domains Added in the Past Month.
optikior.com
OptiKira
Modulating the terminal unfolded protein response. Founded in 2014, OptiKira is advancing discoveries made by a team from The University of California, San Francisco and the University of Washington. Extensive research by our academic founders has helped define the biological pathway leading to progressive cell death which characterizes diseases such as retinitis pigmentosa, diabetes, and amyotrophic lateral sclerosis (ALS). Read more on the development of our novel therapeutics.
Brillenspezialgeschäft I S E L I N
41 (0)44 262 44 41. 9 bis 12 Uhr und 13.30 bis 18.30. 9 bis 16 Uhr. Sonntag und Montag geschlossen.
Hoşgeldiniz
optikist.com - This website is for sale! - optikist Resources and Information.
Error Page cannot be displayed. Please contact your service provider for more details. (14).
optikistanbul.com | Isimtescil.net | Ücretsiz yapım aşamasında sayfası
Lütfen en kısa sürede tekrar ziyaret ediniz. Alan Adı kaydı ve hostingi IsimTescil.NET.
